Celia Dominguez

3.7k total citations
79 papers, 2.2k citations indexed

About

Celia Dominguez is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Celia Dominguez has authored 79 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 29 papers in Cellular and Molecular Neuroscience and 24 papers in Organic Chemistry. Recurrent topics in Celia Dominguez's work include Genetic Neurodegenerative Diseases (23 papers), Neurological disorders and treatments (13 papers) and Mitochondrial Function and Pathology (11 papers). Celia Dominguez is often cited by papers focused on Genetic Neurodegenerative Diseases (23 papers), Neurological disorders and treatments (13 papers) and Mitochondrial Function and Pathology (11 papers). Celia Dominguez collaborates with scholars based in United States, United Kingdom and Belgium. Celia Dominguez's co-authors include Matthew R. Lee, Ignacio Muñoz-Sanjuán, Nuria Tamayo, Longbin Liu, David Powers, Ning Xi, Paul J. Reider, Mike Frohn, John Wityak and Maria Beconi and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Celia Dominguez

79 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Celia Dominguez United States 27 1.1k 697 412 233 160 79 2.2k
Robert L. Hudkins United States 24 1.3k 1.2× 650 0.9× 309 0.8× 364 1.6× 202 1.3× 89 2.2k
Na Ye China 28 1.2k 1.1× 692 1.0× 249 0.6× 250 1.1× 82 0.5× 77 2.4k
Wenhua Chu United States 26 1.1k 1.0× 430 0.6× 346 0.8× 332 1.4× 75 0.5× 51 1.9k
Simona Daniele Italy 31 1.4k 1.3× 508 0.7× 448 1.1× 416 1.8× 154 1.0× 129 3.0k
Russell Dahl United States 34 1.7k 1.5× 481 0.7× 442 1.1× 351 1.5× 132 0.8× 71 2.8k
Jan Passchier United Kingdom 28 775 0.7× 662 0.9× 488 1.2× 262 1.1× 48 0.3× 67 2.8k
Paul Jackson United States 22 809 0.7× 407 0.6× 509 1.2× 367 1.6× 51 0.3× 43 1.7k
Mingzhang Gao United States 22 564 0.5× 494 0.7× 183 0.4× 263 1.1× 61 0.4× 89 1.6k
Sabrina Taliani Italy 36 1.8k 1.6× 1.2k 1.7× 490 1.2× 622 2.7× 153 1.0× 145 3.6k
Mojgan Aghazadeh Tabrizi Italy 37 1.8k 1.6× 1.9k 2.8× 469 1.1× 291 1.2× 119 0.7× 104 4.0k

Countries citing papers authored by Celia Dominguez

Since Specialization
Citations

This map shows the geographic impact of Celia Dominguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celia Dominguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celia Dominguez more than expected).

Fields of papers citing papers by Celia Dominguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celia Dominguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celia Dominguez. The network helps show where Celia Dominguez may publish in the future.

Co-authorship network of co-authors of Celia Dominguez

This figure shows the co-authorship network connecting the top 25 collaborators of Celia Dominguez. A scholar is included among the top collaborators of Celia Dominguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celia Dominguez. Celia Dominguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomsen, Maren, Stefan Steinbacher, Vinay Dahiya, et al.. (2025). Elucidation of multiple high-resolution states of human MutSβ by cryo-EM reveals interplay between ATP/ADP binding and heteroduplex DNA recognition. Nucleic Acids Research. 53(12). 1 indexed citations
2.
Verhaeghe, Jeroen, Alan Miranda, Ignacio Muñoz-Sanjuán, et al.. (2024). Preclinical evaluation of the novel [18F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's disease. European Journal of Nuclear Medicine and Molecular Imaging. 52(1). 122–133. 3 indexed citations
3.
Bertoglio, Daniele, Alison R. Weiss, William A. Liguore, et al.. (2023). In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using11C-CHDI-180R PET in a Nonhuman Primate Model of Huntington Disease. Journal of Nuclear Medicine. 64(10). 1581–1587. 8 indexed citations
4.
Cariulo, Cristina, Margherita Verani, Leticia Toledo‐Sherman, et al.. (2023). IKBKB reduces huntingtin aggregation by phosphorylating serine 13 via a non-canonical IKK pathway. Life Science Alliance. 6(10). e202302006–e202302006. 2 indexed citations
5.
Vignone, Domenico, Odalys Gonzalez Paz, Antonella Cellucci, et al.. (2022). Modelling the Human Blood–Brain Barrier in Huntington Disease. International Journal of Molecular Sciences. 23(14). 7813–7813. 15 indexed citations
6.
Bertoglio, Daniele, Alan Miranda, Sigrid Stroobants, et al.. (2022). Validation, kinetic modeling, and test-retest reproducibility of [18F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in mice. Journal of Cerebral Blood Flow & Metabolism. 42(10). 1867–1878. 15 indexed citations
7.
Marco, Annalise Di, Domenico Vignone, Odalys Gonzalez Paz, et al.. (2020). Establishment of an in Vitro Human Blood-Brain Barrier Model Derived from Induced Pluripotent Stem Cells and Comparison to a Porcine Cell-Based System. Cells. 9(4). 994–994. 27 indexed citations
8.
Cariulo, Cristina, Margherita Verani, Raffaele Ingenito, et al.. (2019). Ultrasensitive quantitative measurement of huntingtin phosphorylation at residue S13. Biochemical and Biophysical Research Communications. 521(3). 549–554. 10 indexed citations
9.
Bresciani, Alberto, Roberto Boggio, Cristina Cariulo, et al.. (2018). Quantifying autophagy using novel LC3B and p62 TR-FRET assays. PLoS ONE. 13(3). e0194423–e0194423. 34 indexed citations
10.
Luckhurst, Christopher A., Omar Aziz, Vahri Beaumont, et al.. (2018). Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor. Bioorganic & Medicinal Chemistry Letters. 29(1). 83–88. 38 indexed citations
11.
Verhaeghe, Jeroen, Daniele Bertoglio, David Thomae, et al.. (2018). Noninvasive Relative Quantification of [11C]ABP688 PET Imaging in Mice Versus an Input Function Measured Over an Arteriovenous Shunt. Frontiers in Neurology. 9. 516–516. 21 indexed citations
12.
Bresciani, Alberto, Antonino Missineo, Mariana Gallo, et al.. (2017). Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1). Archives of Biochemistry and Biophysics. 631. 31–41. 42 indexed citations
13.
Häggkvist, Jenny, Miklós Tóth, Katarina Varnäs, et al.. (2016). Longitudinal Small-Animal PET Imaging of the zQ175 Mouse Model of Huntington Disease Shows In Vivo Changes of Molecular Targets in the Striatum and Cerebral Cortex. Journal of Nuclear Medicine. 58(4). 617–622. 14 indexed citations
14.
Beaumont, Vahri, James M. Watson, Maria Beconi, et al.. (2014). Efficacy of Selective PDE4D Negative Allosteric Modulators in the Object Retrieval Task in Female Cynomolgus Monkeys (Macaca fascicularis). PLoS ONE. 9(7). e102449–e102449. 23 indexed citations
15.
Todd, Daniel G., Simon DOWLER, Michael D. Wall, et al.. (2014). A Monoclonal Antibody TrkB Receptor Agonist as a Potential Therapeutic for Huntington’s Disease. PLoS ONE. 9(2). e87923–e87923. 70 indexed citations
16.
Müller, Ilka, Marieke Lamers, Alison J. Ritchie, et al.. (2011). Structure of human caspase-6 in complex with Z-VAD-FMK: New peptide binding mode observed for the non-canonical caspase conformation. Bioorganic & Medicinal Chemistry Letters. 21(18). 5244–5247. 13 indexed citations
17.
Maillard, Michel, Frederick A. Brookfield, Stephen M. Courtney, et al.. (2011). Exploiting differences in caspase-2 and -3 S2 subsites for selectivity: Structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors. Bioorganic & Medicinal Chemistry. 19(19). 5833–5851. 29 indexed citations
18.
Zeng, Qingping, Matthew P. Bourbeau, Holger Monenschein, et al.. (2010). 2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics. Bioorganic & Medicinal Chemistry Letters. 20(5). 1652–1656. 15 indexed citations
19.
Ross, Sandra L., Teresa C. Chen, Violeta Yu, et al.. (2006). High-Content Screening Analysis of the p38 Pathway: Profiling of Structurally Related p38 α Kinase Inhibitors Using Cell-Based Assays. Assay and Drug Development Technologies. 4(4). 397–409. 15 indexed citations
20.
Lee, Matthew R. & Celia Dominguez. (2005). MAP Kinase p38Inhibitors: Clinical Results and an Intimate Look at Their Interactions with p38α Protein. Current Medicinal Chemistry. 12(25). 2979–2994. 193 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026